Business Description
SpectraCure AB
ISIN : SE0007158118
Compare
Compare
Traded in other countries / regions
SPEC.Sweden2OK.Germany IPO Date
2015-06-29Description
SpectraCure AB develops treatment planning and laser light dose management for cancer treatment. The Company has developed its software IDOSE, and medical laser devices for the treatment.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 7.4 | |||||
Equity-to-Asset | 0.88 | |||||
Debt-to-Equity | 0.05 | |||||
Debt-to-EBITDA | -0.35 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -10.5 | |||||
3-Year EPS without NRI Growth Rate | -7.5 | |||||
3-Year FCF Growth Rate | -19.9 | |||||
3-Year Book Growth Rate | -13 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 42.63 | |||||
9-Day RSI | 44.39 | |||||
14-Day RSI | 44.64 | |||||
6-1 Month Momentum % | -34.01 | |||||
12-1 Month Momentum % | -57.79 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.82 | |||||
Quick Ratio | 3.82 | |||||
Cash Ratio | 3.61 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -1.68 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -15.63 | |||||
ROA % | -14.08 | |||||
ROIC % | -25.14 | |||||
ROC (Joel Greenblatt) % | -312.15 | |||||
ROCE % | -14.88 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 1.95 | |||||
Price-to-Tangible-Book | 5.77 | |||||
EV-to-EBIT | -9.43 | |||||
EV-to-EBITDA | -10.48 | |||||
EV-to-FCF | -6.44 | |||||
Price-to-Net-Current-Asset-Value | 6.93 | |||||
Price-to-Net-Cash | 7.58 | |||||
Earnings Yield (Greenblatt) % | -10.61 | |||||
FCF Yield % | -13.58 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SpectraCure AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | |||
EPS (TTM) (kr) | -0.21 | ||
Beta | 0 | ||
Volatility % | 56.27 | ||
14-Day RSI | 44.64 | ||
14-Day ATR (kr) | 0.183934 | ||
20-Day SMA (kr) | 2.456 | ||
12-1 Month Momentum % | -57.79 | ||
52-Week Range (kr) | 2 - 6.4 | ||
Shares Outstanding (Mil) | 97.13 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
SpectraCure AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
SpectraCure AB Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
SpectraCure AB Frequently Asked Questions
What is SpectraCure AB(OSTO:SPEC)'s stock price today?
The current price of OSTO:SPEC is kr2.42. The 52 week high of OSTO:SPEC is kr6.40 and 52 week low is kr2.00.
When is next earnings date of SpectraCure AB(OSTO:SPEC)?
The next earnings date of SpectraCure AB(OSTO:SPEC) is 2024-08-15.
Does SpectraCure AB(OSTO:SPEC) pay dividends? If so, how much?
SpectraCure AB(OSTO:SPEC) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |